HEALTH

Parents seek homeopathy for household

BY Michael Johnsen

A sick child leads to one certainty: parents in search of safe and effective symptom relievers that will allow their child — and subsequently, themselves — to get some rest.

That movement toward homeopathic remedies is reflected in the sales data. For example, SymphonyIRI Group vendor-level data for the 52 weeks ended Dec. 30, 2012, in the cough syrup sub-category, both Similasan and Hyland’s outpaced category growth of 4.6% with growth rates of 53.1% and 58.5%, respectively. And across cold and allergy liquid formulations, growth of No. 10 brand Hyland’s was tracking at 46.7% versus 11.5% for that entire category.

This cough-cold season Hyland’s launched its Defend-Plus line, an homeopathic cough-cold symptom reliever for adults. Hyland’s already has a share of the pediatric cough-cold market. Defend-Plus will help Hyland’s reach the mom buying cold medicines for the rest of the family.

 

 

The article above is part of the DSN Category Review Series. For the complete Homeopathy Buy-In Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

Natural products to bloom in sales

BY Michael Johnsen

Homeopathy is hopping. Sales of many of the homeopathy brands represent some of the fastest-growing products across the OTC landscape these days, as evidenced by the number of brands escalating on the top 10 lists across several categories. Overall, sales of homeopathic medicines totaled $1.3 billion for the 52 weeks ended Dec. 22, up 8% according to SPINS, which tracks sales across both the natural channel (excluding Whole Foods) and mass retailers.

According to a survey conducted by the market research firm Kline, more than 45% of consumers consider natural OTCs like homeopathic products effective. And more than 40% believe that natural OTCs are safer and/or have fewer side effects than traditional OTCs.

Business opportunities vary across product categories, noted Laura Mahecha, industry manager at Kline’s Healthcare practice. "For instance, while cough and cold preparations are expected to grow at a rate of only 5% to reach $320.9 billion in 2016, it is anticipated that sleeping aids will grow by about 18% per year to reach $54 million in 2016 from $23.5 million reported in 2011," she said. "Growth in natural OTCs will be dependent on whether consumers continue to find them effective and safe."

Beyond opportunities within sleep, external analgesics containing arnica may become another growth driver. "You’re going to see the leg cramps and the arnica really come full force in the next 12 months," said Les Hamilton, VP sales for Hyland’s. Menthol rubs are common across the category, he added, and the homeopathic external analgesic solutions could supply some "newness" to the category.

 

 

The article above is part of the DSN Category Review Series. For the complete Homeopathy Buy-In Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?
HEALTH

DSN Flu Tracker: Illustrating the 2012-2013 season

BY Michael Johnsen

There were more sick people cruising the cold relief aisles this year. According to the Centers for Disease Control and Prevention, flu incidence peaked at 6.1% this season, making this season the most virulent since the 2007-2008 season — excepting the H1N1 pandemic in 2009, which was atypical.

With that in mind, sales of cough and cold medicines — or sales of just about anything else that had something to do with the flu, from hand sanitizers to flu shots — were through the roof.

To watch the DSN Flu Tracker slideshow, loaded with key data, including sales in core OTC cough-cold categories during the thick of cold and flu activity, visit click here.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

POLLS

Which area of the industry do you think Amazon’s entry would shake up the most?